EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement

Shanti D M Khargi iD, Pepijn Grashuis iD, Kevin M Veen iD, Jolanda Kluin iD, Jérôme M J Cornette iD, Mark R Johnson iD, Jolien W Roos-Hesselink iD, Johanna J M Takkenberg iD, Mostafa M Mokhles iD

European Journal of Cardio-Thoracic Surgery · 01.04.2026 · 68 (4)

DOI: 10.1093/ejcts/ezag137 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 26.03.2026. Verfasst von Shanti D M Khargi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Erasmus Medical Centre, Rotterdam,The Netherlands. Hauptthemen laut MEDLINE: Heart Valve Prosthesis Implantation, Aortic Valve, Heart Valve Prosthesis, Pregnancy Outcome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the optimal valve substitute for young women requiring aortic valve replacement (AVR), allowing improved future valve-related outcomes for mother and foetus during pregnancy.

Methods

A systematic search was performed for publications between 1998 and 2025 reporting women experiencing pregnancy after AVR with a pulmonary autograft (Ross-procedure), homograft, bioprosthesis (xenograft), or mechanical valve. Pooled proportions were calculated to determine maternal, valvular and foetal outcomes during pregnancy using generalized linear mixed models.

Results

Thirteen studies reporting 356 pregnancies in 251 women (pooled mean age at pregnancy 29.1 ± 4.8 years) after AVR with a pulmonary autograft (70 women, 119 pregnancies), homograft (73 women, 99 pregnancies), bioprosthesis (37 women, 50 pregnancies), or mechanical valve (71 women, 88 pregnancies) were included. During pregnancy, valve-related reintervention in women with a bioprosthesis was 2.7% (95% CI, 0.4-16.9) at 5.1 ± 2.5 years after AVR. This was not observed in women with pulmonary autografts (7.7 ± 4.2 years after AVR) and homografts (4.1 ± 3.3 years after AVR). Reintervention for valve thrombosis (4.9% [95% CI, 1.6-14.0]) and maternal death (1.1% [95% CI, 0.2-7.6]) occurred only in women with mechanical valves (8.1 ± 4.5 years after AVR). Pooled probability of liveborn delivery was 71.7% (95% CI, 59.2-81.6) in women with a mechanical valve, compared to 90.6% (95% CI, 72.4-97.3), 92.3% (95% CI, 56.0-99.1), and 82.9% (95% CI, 53.3-95.4) in women with an autograft, homograft, and bioprosthesis respectively.

Conclusions

Maternal mortality and valve thrombosis during pregnancy occurred only in women with mechanical valves. Although no statistical comparisons were made, pregnancies in women with pulmonary autograft, homograft or bioprosthesis showed acceptable maternal and foetal outcomes. These descriptive findings provide foundations for further investigation of tissue-valve function before, during and after pregnancy, aiming for more support of current guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve Prosthesis ImplantationAortic ValveHeart Valve ProsthesisPregnancy OutcomePregnancy Complications, CardiovascularHumansFemalePregnancyBioprosthesisAdult

Stichwörter der Autor:innen

Ross-procedureaortic valve replacementbioprosthesishomograftmechanical valvepregnancy

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Erasmus Medical Centre, Rotterdam,The Netherlands.
  • Department of Obstetrics and Gynaecology, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Department of Obstetrics and Gynaecology, University of Antwerp, Antwerp, Belgium.
  • Department of Obstetric Medicine, Imperial College London, Kensington, London, United Kingdom.
  • Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Department of Cardiothoracic Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Shanti D M Khargi, Pepijn Grashuis, Kevin M Veen, Jolanda Kluin, Jérôme M J Cornette, Mark R Johnson, Jolien W Roos-Hesselink, Johanna J M Takkenberg, Mostafa M Mokhles

Zitieren

APA

Khargi, S. D. M., Grashuis, P., Veen, K. M., Kluin, J., Cornette, J. M. J., Johnson, M. R., Roos-Hesselink, J. W., Takkenberg, J. J. M., & Mokhles, M. M. (2026). Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement. European Journal of Cardio-Thoracic Surgery, 68(4). https://doi.org/10.1093/ejcts/ezag137

Vancouver

Khargi SDM, Grashuis P, Veen KM, Kluin J, Cornette JMJ, Johnson MR, et al. Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement. European Journal of Cardio-Thoracic Surgery. 2026;68(4). doi:10.1093/ejcts/ezag137

BibTeX
@article{Khargi2026,
  author = {Khargi, Shanti D M and Grashuis, Pepijn and Veen, Kevin M and Kluin, Jolanda and Cornette, Jérôme M J and Johnson, Mark R and Roos-Hesselink, Jolien W and Takkenberg, Johanna J M and Mokhles, Mostafa M},
  title = {Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  volume = {68},
  number = {4},
  doi = {10.1093/ejcts/ezag137}
}
Kostenlos starten →